Dexcom Wear & Learn
Hands-On Training


Get to know the Dexcom portfolio

FMX 2026 | Nashville, TN

Register today

Experience Dexcom G7 15 Day or Stelo by Dexcom from the user perspective. Participants will receive a sensor to experience and explore personalized glucose insights through the in-app features.

To view eligibility and participation requirements, click here.



Experience offered at
FMX 2026


When:
October 21 - 23, 2026

Where:
Dexcom Booth #1823

Trial Times and Dates:

Wednesday, Oct 21:
5:00 PM - 7:30 PM

Thursday, Oct 22:
9:00 AM - 3:15 PM

Friday, Oct 23:
9:00 AM - 11:30 AM
1:30 PM - 3:15 PM

All times in CST



To register, please complete the form below.
This experience is available to United States participants only.
Basic details
(*Required)
Professional Details
×
×
×
Only Stelo by Dexcom is available for trial.
Stay Connected
Disclaimers
By entering my initials, I confirm that all information in the form is true and accurate to the best of my knowledge. I confirm that I am a U.S. licensed healthcare professional or student in good standing. If applicable, I will comply with the laws of my licensing jurisdiction(s) regarding use of medical device samples.

All transfers of value (TOVs) to healthcare professionals (HCPs) will be reported as required under Federal or State law. By participating in this activity, you understand the value of any provided transfers of value will be reported and that the information will be publicly available.
Submit
This program is not part of FMX 2026 as planned by the American Academy of Family Physicians. This event is neither sponsored nor endorsed by the American Academy of Family Physicians. This event does not qualify for continuing medical education (CME) credit.

†For Dexcom G7 15 Day compatibility information, visit dexcom.com/compatibility. For Stelo app compatibility information, please visit stelo.com/compatibility. ‡Participants are required to have a United States based Google/Apple account to download the Stelo app.

BRIEF SAFETY STATEMENT: Failure to use the Dexcom Continuous Glucose Monitoring System and its components according to the instructions for use provided with your device and available at https://www.dexcom.com/safety-information and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the Dexcom CGM do not match symptoms, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency.

STELO IMPORTANT INFORMATION: Consult your healthcare provider before making any medication adjustments based on your sensor readings and do not take any other medical action based on your sensor readings without consulting your healthcare provider. Do not use if you have problematic hypoglycemia. Failure to use Stelo and its components according to the instructions for use provided and to properly consider all indications, contraindications, warnings, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence. If your sensor readings are not consistent with your symptoms, a blood glucose meter may be an option as needed and consult your healthcare provider. Seek medical advice and attention when appropriate, including before making any medication adjustments and/or for any medical emergency.

INDICATIONS FOR USE: The Stelo Glucose Biosensor System is an over-the-counter (OTC) integrated Continuous Glucose Monitor (iCGM) intended to continuously measure, record, analyze, and display glucose values in people 18 years and older not on insulin. The Stelo Glucose Biosensor System helps to detect normal (euglycemic) and low or high (dysglycemic) glucose levels. The Stelo Glucose Biosensor System may also help the user better understand how lifestyle and behavior modification, including diet and exercise, impact glucose excursion. The user is not intended to take medical action based on the device output without consultation with a qualified healthcare professional.

Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, Stelo, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries.

© 2026 Dexcom, Inc. All rights reserved.
MAT-13797